Patient blood management: Where's the bottom?

Transfusion

Volumn 55, Issue 4, 2015, Pages 700-702

  Waters, Jonathan H ^a   Yazer, Mark H ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; BACTERIAL INFECTION; BLOOD TRANSFUSION; CRITICALLY ILL PATIENT; DECISION MAKING; EDITORIAL; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEART SURGERY; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MEDICAL SCHOOL; PATIENT CARE; SEPSIS; TRAUMATIC BRAIN INJURY; UTILIZATION;

BLOOD TRANSFUSION; HUMANS;

EID: 84926467644     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13063     Document Type: Editorial

References (22)

1. Pfuntner A, Wier LM, Stocks C., Most frequent procedures performed in U.S. hospitals, 2010. Statistical Brief #149. Healthcare Cost and Utilization Report. Rockville (MD): Agency for Healthcare Research and Quality; 2013 Feb. pp 1-9.
2. Qian F, Osler TM, Eaton MP, et al. Variation in blood transfusion in patients undergoing major noncardiac surgery. Ann Surg 2013; 257: 266-78.
3. Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010; 304: 1568-75.
4. Verlicchi F, Desalvo F, Zanotti G, et al. Red cell transfusion in orthopaedic surgery: a benchmark study performed combining data from different data sources. Blood Transfus 2011; 9: 383-7.
5. Snyder-Ramos SA, Möhnle P, Weng Y, et al. The ongoing variability in blood transfusion practices in cardiac surgery. Transfusion 2008; 48: 1284-99.
6. Brown RL, Edwards JA, Nutz JF,. Variation in a medical faculty's decisions to transfuse. Implications for modifying blood product utilization. Med Care 1992; 30: 1083-96.
7. Yazer MH, Triulzi DJ., Things aren't always as they seem: what the randomized trials of red blood cell transfusion tell us about adverse outcomes (CME). Transfusion 2014; 54: 3243-6.
8. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17.
9. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62.
10. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
11. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559-67.
12. Song HK, von Heymann C, Jespersen CM, et al. Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations. Ann Thorac Surg 2014; 97: 1630-5.
13. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-91.
14. Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356: 1609-19.
15. Fan YX, Liu FF, Jia M, et al. Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: a preliminary study. Arch Gerontol Geriatr 2014; 59: 181-5.
16. Robertson CS, Hannay HJ, Yamal JM, et al,., Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA 2014; 312: 36-47.
17. Salpeter SR, Buckley JS, Chatterjee S,. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 2014; 127: 124-31.
18. Hibbs S, Miles D, Staves J, et al. Is undertransfusion a problem in modern clinical practice? Transfusion 2015; 55: 000-00.
19. Mair B, Agosti SJ, Foulis PR, et al. Monitoring for under transfusion. Transfusion 1996; 36: 533-5.
20. Saxena S, Wehrli G, Makarewicz K, et al. Monitoring for underutilization of RBC components and platelets. Transfusion 2001; 41: 587-90.
21. Slichter SJ, Harker LA,. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol 1978; 523-39.
22. Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362: 600-13.